MIYAGI HENDERSON: Open Payments
NPI 1588293518 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,119 in 235 payments from 19 companies in 2025. Trend: 2023 $3,330 · 2024 $3,354 · 2025 $4,119
Food & beverage: $4,089Education: $30
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 67 | $928 |
| ABBVIE INC. | 40 | $707 |
| Galderma Laboratories, L.P. | 40 | $529 |
| GENZYME CORPORATION | 17 | $399 |
| Regeneron Healthcare Solutions, Inc. | 12 | $278 |
| LEO Pharma Inc. | 12 | $225 |
| Arcutis Biotherapeutics, Inc. | 9 | $183 |
| Incyte Corporation | 6 | $178 |
| Novartis Pharmaceuticals Corporation | 4 | $166 |
| Amgen Inc. | 5 | $92 |
Products named: Bimzelx, DUPIXENT, NEMLUVIO, SKYRIZI, RINVOQ, Zoryve, OPZELURA, ADBRY.
Industry payments across LA — which companies pay providers there.
